icotec AG, a Swiss medtech company pioneering the development of implants for spine tumor stabilization, has secured $30m growth financing from MVM Partners, a renowned venture capital firm with over $1 billion assets under management. The financial boost will support icotec’s market growth and strengthen its R&D capabilities to expand the product portfolio into the underserved indications of spinal infection and osteoporosis.
